Literature DB >> 25748100

Spinal cord pathology in multiple sclerosis.

Hans Lassmann1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25748100     DOI： 10.1016/S1474-4422(15)70037-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  [Immunotherapy and infectious issues in multiple sclerosis. Self-injectable and oral drugs for immunotherapy].

Authors:  A Winkelmann; M Löbermann; E C Reisinger; H-P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 2.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

3.  NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity.

Authors:  C Alcalá; L Cubas; S Carratalá; F Gascón; C Quintanilla-Bordás; S Gil-Perotín; D Gorriz; F Pérez-Miralles; R Gasque; J Castillo; B Casanova
Journal:  J Neurol       Date:  2022-01-17       Impact factor: 4.849

4.  Magnetic Resonance Imaging of Spinal Cord Lesions in Patients with Multiple Sclerosis in Saskatchewan, Canada.

Authors:  Aman Saini; Kevin Bach; Ilia Poliakov; Katherine B Knox; Michael C Levin
Journal:  Int J MS Care       Date:  2020-04-14

Review 5.  Advances in spinal cord imaging in multiple sclerosis.

Authors:  Marcello Moccia; Serena Ruggieri; Antonio Ianniello; Ahmed Toosy; Carlo Pozzilli; Olga Ciccarelli
Journal:  Ther Adv Neurol Disord       Date:  2019-04-22       Impact factor: 6.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.